Decision points for individualized hormonal stimulation with recombinant gonadotropins for treatment of women with infertility

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
B LunenfeldSesh K Sunkara

Abstract

It is essential that fertility treatment is individualized based on a thorough diagnostic work-up, with treatment tailored to the patients' requirements. This individualization should be kept in mind during the main decision points that occur before and during treatment. Treatment customization must include consideration of both the woman and her partner involved in the process together, including their collective treatment goals. Once treatment goals have been agreed and diagnostic evaluations performed, personalization based on patient characteristics, together with an understanding of treatment goals and patient preferences, enables the selection of appropriate treatments, protocols, products and their dosing. Following treatment initiation, monitoring and adaptation of product and dose can then ensure optimal outcomes. Currently, it is not possible to base treatment decisions on every characteristic of the patient and personalization is based on biomarkers that have been identified as the most relevant. However, in the future, the use of artificial intelligence coupled with continuous monitoring should enable greater individualization and improve outcomes. This review considers the current state-of-the-art related to decisi...Continue Reading

References

Jan 1, 1959·Acta Obstetricia Et Gynecologica Scandinavica·R BORTH de WATTEVILLE
Oct 24, 2006·Fertility and Sterility·UNKNOWN Practice Committee of the American Society for Reproductive Medicine
Jan 14, 2011·Journal de gynécologie, obstétrique et biologie de la reproduction·UNKNOWN Collège national des gynécologues et obstétriciens français
Apr 21, 2011·Human Reproduction·A P FerrarettiUNKNOWN ESHRE working group on Poor Ovarian Response Definition
Dec 3, 2011·Reproductive Biomedicine Online·Jyotsna PundirYacoub Khalaf
Nov 20, 2013·Human Fertility : Journal of the British Fertility Society·Ephia Yasmin British Fertility Society
Mar 1, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Joan-Carles ArceAntonio La Marca
Jul 11, 2014·Human Reproduction·Anna Pia Ferraretti, Luca Gianaroli
Oct 11, 2014·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·Carolina O NastriWellington P Martins
Jul 24, 2015·Human Reproduction·N P Polyzos, S K Sunkara
Oct 31, 2015·Systems Biology in Reproductive Medicine·Itai GatClifford L Librach
Nov 19, 2015·Journal of Ovarian Research·Johnny S YounisIzhar Ben-Shlomo
Feb 28, 2016·Fertility and Sterility·UNKNOWN Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number)Peter Humaidan
Sep 16, 2016·Reproductive Sciences·Laurice Bou NemerSteven J Ory
Mar 10, 2017·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Pinar ÖzcanMert Yesiladali
Apr 20, 2017·Methods in Molecular Biology·Tammie K RoyTeija T Peura
May 26, 2017·Journal of Diabetes Science and Technology·Mercedes RiglaMaria Elena Hernando
Aug 2, 2017·Reproductive Biomedicine Online·William SchoolcraftUNKNOWN Global Fertility Alliance. Electronic address: alan.thornhill@igenomix.com
Nov 9, 2017·Human Reproduction·Fernando Zegers-HochschildSheryl van der Poel
Nov 15, 2017·Human Reproduction·Åsa MagnussonChristina Bergh
Nov 22, 2017·Clinical Imaging·Ray Cody Mayo, Jessica Leung
Feb 17, 2018·Human Reproduction Update·Ben CohlenWillem Ombelet
Mar 7, 2018·Stroke and Vascular Neurology·Fei JiangYongjun Wang
Apr 15, 2018·Fertility and Sterility·Carlo AlviggiUNKNOWN International Collaborative Group for the Study of r-hLH (iCOS-LH)
Apr 18, 2018·Current Opinion in Obstetrics & Gynecology·Biljana Popovic-TodorovicChristophe Blockeel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Duodecim; lääketieteellinen aikakauskirja
Kimmo PorkkaPasi Pöllänen
Medical Decision Making : an International Journal of the Society for Medical Decision Making
Anirban Basu, David Meltzer
© 2021 Meta ULC. All rights reserved